# Insulin Glargine Versus Regular Insulin Based Regimens in Glycemic Control After Acute Stroke

Study · id `cardio:ct-nct02607943` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02607943](<https://clinicaltrials.gov/study/NCT02607943>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02607943

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

## Technical summary

Registry record NCT02607943. Randomized; no masking; primary purpose treatment. Start 2015-12 (registry gives no type); primary completion 2018-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT02607943, source copy `cardio:ctgov-nct02607943-2016-08-19`, retrieved 2026-10-26)
- Start date: 2015-12 (registry gives no type) (ClinicalTrials.gov record NCT02607943, source copy `cardio:ctgov-nct02607943-2016-08-19`, retrieved 2026-10-26)
- Primary completion: 2018-07 (anticipated) (ClinicalTrials.gov record NCT02607943, source copy `cardio:ctgov-nct02607943-2016-08-19`, retrieved 2026-10-26)
- Completion: 2018-11 (anticipated) (ClinicalTrials.gov record NCT02607943, source copy `cardio:ctgov-nct02607943-2016-08-19`, retrieved 2026-10-26)
- Countries: Taiwan (ClinicalTrials.gov record NCT02607943, source copy `cardio:ctgov-nct02607943-2016-08-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02607943-2016-08-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Insulin Glargine Versus Regular Insulin Based Regimens in Glycemic Control After Acute Stroke
- Acronym: ICAS
- Condition: Acute Stroke
- Condition: Hyperglycemia
- Intervention (Drug): Insulin Glargine
- Intervention (Drug): Regular Insulin
- Lead sponsor: National Taiwan University Hospital
- Lead sponsor class: OTHER
- Collaborator: Chang Gung Memorial Hospital
- Collaborator class: OTHER
- Collaborator: Taipei Medical University Shuang Ho Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: National Taiwan University Hospital (`cardio:org-national-taiwan-university-hospital`)
- Registry lists this organization as a collaborator: Chang Gung Memorial Hospital (`cardio:org-chang-gung-memorial-hospital`)
- Registry lists this organization as a collaborator: Taipei Medical University Shuang Ho Hospital (`cardio:org-taipei-medical-university-shuang-ho-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: A randomized trial to investigate the efficacy and safety of insulin glargine in hyperglycemic acute stroke patients receiving intensive care (`cardio:pubmed-34075142`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: aea39e5e0e9c3b08adc6d6aaececd9b800f291e92b2cc033c1b20118d036e0d3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
